Oprah Winfrey, the celebrated US star, has been openly battling her weight issues for a long time, often expressing the humiliation she experiences due to media scrutiny. In her recent special, “Shame, Blame, and the Weight Loss Revolution,” Winfrey shared that she uses a prescription drug for weight loss.

This impactful revelation came during a discussion with representatives from Eli Lilly and Novo Nordisk, the makers of weight loss drugs Ozempic & Wegovy. Winfrey explored the influence of such drugs on patients, bringing out her personal battles and endeavours with weight loss.

The special served as a platform for Winfrey to recount her struggles and promote awareness about the increasing usage and effectiveness of GLP-1 drugs in obesity management. Thus, it shed light on a significant aspect of the expanding $80 billion obesity shot market.

Pharmaceutical giants Novo Nordisk A/S and Eli Lilly & Co. greatly benefited from the positive publicity ignited by Winfrey’s honest admission and discussion. Overall, “An Oprah Special: Shame, Blame, and the Weight Loss Revolution” marked a significant point in taking the conversation about weight issues and related treatments forward.